Inflammatory Arthritis following Hepatitis B Vaccination in an Infant

Sana S Rahimi1,2, Barbara E Ostrov2, Maricarmen Lopez-Pena2

  • 1Department of Primary Care Pediatrics, Nemours Children's Health System, Milford, DE, USA.

Insights

A rare case of inflammatory arthritis in an infant developed after the hepatitis B vaccine. This post-vaccination arthritis, linked to HLA B27, highlights a potential adverse event in children.

Area of Science:

  • Pediatric rheumatology
  • Vaccine safety
  • Immunology

Background:

  • Inflammatory arthritis in children can be idiopathic or infection-related.
  • Post-vaccination inflammatory arthritis is rarely reported in pediatric populations.
  • The hepatitis B vaccine is a common childhood immunization.

Observation:

  • A 10-day-old infant presented with right lower extremity decreased movement and knee swelling.
  • The infant received a hepatitis B vaccine in the right thigh at birth.
  • Clinical presentation suggested inflammatory arthritis with a negative ANA but positive HLA B27.

Findings:

  • The infant's symptoms resolved with ibuprofen treatment.
  • Literature review revealed adult cases of reactive arthritis post-hepatitis B vaccination, often HLA B27 associated.
  • This is the first reported pediatric case of inflammatory arthritis following hepatitis B vaccination.

Implications:

  • Healthcare providers should consider post-vaccination inflammatory arthritis in infants presenting with joint swelling and pain.
  • Awareness of this rare adverse event is crucial for timely diagnosis and management.
  • Further research may be needed to understand the mechanism and incidence of vaccine-associated arthritis in children.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
154
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
561
Cross-reactivity00:42

Cross-reactivity

Overview
31.9K
Vaccinations01:51

Vaccinations

Overview
48.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
46
Inflammation01:38

Inflammation

Overview
57.2K